SmartinBio
- Biotech or pharma, therapeutic R&D
SmartinBio is a biotechnology company developing first-in-class mitochondrial-targeted therapeutics for resistant and relapsed acute myeloid leukemia (AML), diabetic retinopathy, Leber’s hereditary optic neuropathy (LHON), and Parkinson’s disease.



